Our scientists use Quality-By-Design (QBD) tools at all stages of formulation development. Design of experiments (DOE) along with risk assessment strategies allows us to design our experimental plan. Our development approach allows us to meet our delivery timelines and helps us in providing our clients with cost-effective drug delivery solutions.
Tablets : Immediate-release, Sustained-release, Delayed-release, Film-coated
Injection : Solution for injection, Powder for injection, Suspension for injection, Non aqueous liquid solution
Capsules : Powder, Granule filling
Pellets : Into tablets or Capsule filled
Powders : Powder in a bottle
Liquids : Solutions, Suspensions, Emulsions
Semi-solids : Creams, Ointments, Gels, Lotions
Veterinary: Spot on, pour on, soft chewable platform, hard chewable flavoured tablets etc.
Direct tablet compression
Fluid bed processing (granulation, drying, coating)
High shear wet granulation
Dry granulation (roller compaction, slugging)
Extrusion spheronization
Perforated pan tablet coating
Automated capsule filling (powder, granules, pellets)
Spray drying
Microencapsulation
Low humidity / moisture requirements
Taste-masking
High potency compound handling
Instrumented tablet press
Formulation development for early safety studies
Prototype formulations for clinical trials
Prototype formulation screening studies
Formulation / process optimization
Preliminary process identification
Commercial formulation development for NME’s, ANDA’s and OTC’s
Process development optimization
Scale up / technology transfer
Liposomal drug delivery technology
Soft chewable tablets for companion animals
Transdermal delivery system
© 2017 Cuckospharma.